Cargando…

Targeting Prostate Cancer Using Intratumoral Cytotopically Modified Interleukin-15 Immunotherapy in a Syngeneic Murine Model

BACKGROUND: The prostate cancer microenvironment is highly immunosuppressive; immune cells stimulated in the periphery by systemic immunotherapies will be rendered inactive once entering this environment. Immunotherapies for prostate cancer need to break this immune tolerance. We have previously ide...

Descripción completa

Detalles Bibliográficos
Autores principales:	Papaevangelou, Efthymia, Smolarek, Dorota, Smith, Richard A, Dasgupta, Prokar, Galustian, Christine
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7394845/ https://www.ncbi.nlm.nih.gov/pubmed/32802803 http://dx.doi.org/10.2147/ITT.S257443

Ejemplares similares

Cytotopic (Cyto-) IL-15 as a New Immunotherapy for Prostate Cancer: Recombinant Production in Escherichia coli and Purification
por: Esteves, Ana M., et al.
Publicado: (2021)

Combination of Interleukin-15 With a STING Agonist, ADU-S100 Analog: A Potential Immunotherapy for Prostate Cancer
por: Esteves, Ana M., et al.
Publicado: (2021)

Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
por: Papaevangelou, Efthymia, et al.
Publicado: (2023)

IL-15 Upregulates Telomerase Expression and Potently Increases Proliferative Capacity of NK, NKT-Like, and CD8 T Cells
por: Watkinson, Fiona, et al.
Publicado: (2021)

Editorial: Immunotherapy for Prostate Cancer – turning the immunological desert into an oasis of hope
por: Galustian, Christine, et al.
Publicado: (2022)

Response of Syngeneic Murine Lymphomata to Immunotherapy in Relation to the Antigencity of the Tumour
por: Parr, Iris
Publicado: (1972)

Immune Profiling of Syngeneic Murine and Patient GBMs for Effective Translation of Immunotherapies
por: Khalsa, Jasneet Kaur, et al.
Publicado: (2021)

Extensive Association of Functionally and Cytotopically Related mRNAs with Puf Family RNA-Binding Proteins in Yeast
por: Gerber, André P, et al.
Publicado: (2004)

Radiosensitizing effect of intratumoral interleukin-12 gene electrotransfer in murine sarcoma
por: Sedlar, Ales, et al.
Publicado: (2013)

Cathepsin-L and transglutaminase dependent processing of ps20: A novel mechanism for ps20 regulation via ECM cross-linking
por: Hickman, Oliver J., et al.
Publicado: (2016)

Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2
por: Hickman, Oliver J, et al.
Publicado: (2016)

Combined innate and adaptive immunotherapy overcomes resistance of immunologically cold syngeneic murine neuroblastoma to checkpoint inhibition
por: Voeller, Julie, et al.
Publicado: (2019)

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy
por: Uher, Ondrej, et al.
Publicado: (2023)

Concanavalin A potentiates syngeneic response in murine lymphocytes
Publicado: (1976)

Optimization of a syngeneic murine model of bone metastasis
por: Farhoodi, Henry P., et al.
Publicado: (2020)

Molecular Mechanisms in Murine Syngeneic Leukemia Stem Cells
por: Chamo, Michael, et al.
Publicado: (2023)

Focal Cryo-Immunotherapy with Intratumoral IL-12 Prevents Recurrence of Large Murine Tumors
por: Vrabel, Maura R., et al.
Publicado: (2023)

Intratumoral Immunotherapy—Update 2019
por: Hamid, Omid, et al.
Publicado: (2019)

Trial watch: intratumoral immunotherapy
por: Humeau, Juliette, et al.
Publicado: (2021)

Immunotherapeutic Agents for Intratumoral Immunotherapy
por: Shyr, Chih-Rong, et al.
Publicado: (2023)

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
por: Anker, Jonathan F., et al.
Publicado: (2018)

Interleukin-15 after Near-Infrared Photoimmunotherapy (NIR-PIT) Enhances T Cell Response against Syngeneic Mouse Tumors
por: Maruoka, Yasuhiro, et al.
Publicado: (2020)

Interleukin 15 in Cell-Based Cancer Immunotherapy
por: Zhou, Yang, et al.
Publicado: (2022)

Research progress of interleukin-15 in cancer immunotherapy
por: Cai, Menghan, et al.
Publicado: (2023)

CCR4 Blockade Diminishes Intratumoral Macrophage Recruitment and Augments Survival of Syngeneic Pancreatic Cancer-Bearing Mice
por: Khabipov, Aydar, et al.
Publicado: (2023)

IMMUNE AND NATURAL ANTIBODIES TO SYNGENEIC MURINE PLASMA CELL TUMORS
por: Herberman, Ronald B., et al.
Publicado: (1972)

Decidual-Placental Immune Landscape During Syngeneic Murine Pregnancy
por: Li, Yan, et al.
Publicado: (2018)

Characterization of immune cell populations in syngeneic murine tumor models
por: Snipstad, Sofie, et al.
Publicado: (2023)

Interleukin-15 in cancer immunotherapy: IL-15 receptor complex versus soluble IL-15 in a cancer cell-delivered murine leukemia model
por: Berger, Alexandra, et al.
Publicado: (2019)

Newcastle disease virus co‐expressing interleukin 7 and interleukin 15 modified tumor cells as a vaccine for cancer immunotherapy
por: Xu, Xiaojing, et al.
Publicado: (2018)

Intratumoral TNFα improves immunotherapy
por: Johansson, Anna, et al.
Publicado: (2012)

Characterization of intratumor microbiome in cancer immunotherapy
por: Zhang, Zhao, et al.
Publicado: (2023)

Treatment of Oligometastatic Hormone-Sensitive Prostate Cancer: A Comprehensive Review
por: Koo, Kyo Chul, et al.
Publicado: (2018)

Contribution of dendritic cells to stimulation of the murine syngeneic mixed leukocyte reaction
Publicado: (1980)

Sex differences in the MB49 syngeneic, murine model of bladder cancer
por: White-Gilbertson, Shai, et al.
Publicado: (2016)

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs
por: Timmons, Joshua J., et al.
Publicado: (2016)

Regression of Atherosclerosis in ApoE−/− Mice Via Modulation of Monocyte Recruitment and Phenotype, Induced by Weekly Dosing of a Novel “Cytotopic” Anti‐Thrombin Without Prolonged Anticoagulation
por: Chen, Daxin, et al.
Publicado: (2020)

Tumor-infiltrating Leukocytes Suppress Local Inflammation Via Interleukin-1 Receptor Antagonist in a Syngeneic Prostate Cancer Model
por: Fan, Yu-Ching, et al.
Publicado: (2020)

A comparative analysis of single port versus multi-port robotic assisted radical prostatectomy for prostate cancer
por: Walsh, Anna L, et al.
Publicado: (2020)

Successful immunotherapy of natural killer-resistant established pulmonary melanoma metastases by the intravenous adoptive transfer of syngeneic lymphocytes activated in vitro by interleukin 2
Publicado: (1984)

Cannot write session to /tmp/vufind_sessions/sess_etig5ttrf2pi5b55763hmo8jhc